SEARCH

SEARCH BY CITATION

References

  • 1
    Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med 2008; 359: 1811-1821.
  • 2
    Edwards NL. The role of hyperuricemia in vascular disorders. Curr Opin Rheumatol 2009; 21: 132-137.
  • 3
    Sanyal AJ. The pathogenesis of NASH: human studies. In: Farrell FJ, George J, de la M, Hall P, McCulloch CE, eds. Fatty Liver Disease: NASH and Related Disorders. Malden, MA: Blackwell; 2005: 76-90.
  • 4
    Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, et al. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008; 134: 416-423.
  • 5
    Centers for Disease Control and Prevention. The Third National Health and Nutrition Examination Survey (NHANES III 1988-1994) Reference Manuals and Reports [CD-ROM]. Bethesda, MD: National Center for Health Statistics; 1996.
  • 6
    Choi HK, Ford ES. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am J Med 2007; 120: 442-447.
  • 7
    Nguyen S, Choi HK, Lustig RH, Hsu CY. Sugar-sweetened beverages, serum uric acid, and blood pressure in adolescents. J Pediatr 2009; 154: 807-813.
  • 8
    NHANES 1999-2000 lab file. http://www.cdc.gov/nchs/nhanes/lab99_00.htm. Accessed April 2010.
  • 9
    NHANES 2001-2002 lab file. http://www.cdc.gov/nchs/nhanes/nhanes2001-2002/lab01_02.htm. Accessed April 2010.
  • 10
    Ioannou GN, Boyko EJ, Lee SP. The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002. Am J Gastroenterol 2006; 101: 76-82.
    Direct Link:
  • 11
    Ioannou GN, Weiss NS, Boyko EJ, Kahn SE, Lee SP. Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease. Gastroenterology 2005; 128: 627-635.
  • 12
    Ioannou GN, Weiss NS, Boyko EJ, Mozaffarian D, Lee SP. Elevated serum alanine aminotransferase activity and calculated risk of coronary heart disease in the United States. HEPATOLOGY 2006; 43: 1145-1151.
  • 13
    Ruhl CE, Everhart JE. Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005; 128: 24-32.
  • 14
    Ruhl CE, Everhart JE. Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population. Gastroenterology 2009; 136: 477-485.
  • 15
    Ioannou GN, Weiss NS, Kowdley KV, Dominitz JA. Is obesity a risk factor for cirrhosis-related death or hospitalization? A population-based cohort study. Gastroenterology 2003; 125: 1053-1059.
  • 16
    Ioannou GN, Weiss NS, Boyko EJ, Kowdley KV, Kahn SE, Carithers RL, et al. Is central obesity associated with cirrhosis-related death or hospitalization? A population-based, cohort study. Clin Gastroenterol Hepatol 2005; 3: 67-74.
  • 17
    Ruhl CE, Everhart JE. Coffee and tea consumption are associated with a lower incidence of chronic liver disease in the United States. Gastroenterology 2005; 129: 1928-1936.
  • 18
    Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
  • 19
    Ingram DD, Makuc DM. Statistical Issues in Analyzing the NHANES I Epidemiologic Follow-Up Study. Hyattsville, MD: National Center for Health Statistics; 1994. Vital and Health Statistics Series 2, no. 121. DHHS publication 94-1395.
  • 20
    Korn EL, Graubard BI. Epidemiologic studies utilizing surveys: accounting for the sampling design. Am J Public Health 1991; 81: 1166-1173.
  • 21
    Li Y, Xu C, Yu C, Xu L, Miao M. Association of serum uric acid level with non-alcoholic fatty liver disease: a cross-sectional study. J Hepatol 2009; 50: 1029-1034.
  • 22
    Lonardo A, Loria P, Leonardi F, Borsatti A, Neri P, Pulvirenti M, et al. Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study. Dig Liver Dis 2002; 34: 204-211.
  • 23
    Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W, et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005; 67: 1739-1742.
  • 24
    Mercuro G, Vitale C, Cerquetani E, Zoncu S, Deidda M, Fini M, et al. Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk. Am J Cardiol 2004; 94: 932-935.
  • 25
    Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007; 293: C584-C596.
  • 26
    Hill RB, Anderson RE. Missed diagnoses: toward an understanding of diagnostic discrepancies. In: Hill RB, Anderson RE, eds. The Autopsy-Medical Practice and Public Policy. Boston, MA: Butterworths; 1988: 68-90.
  • 27
    Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 1999; 130: 461-470.